Analytical Data
-
Gene name
CENTa1
- Application
-
Alternative Names
CENT-A1; ADAP1; GCS1L; P42IP4; Arf-GAP with dual PH domain-containing protein 1; Putative MAPK-activating protein PM25
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O75689
-
Expression Region
Ser45~Asp356
-
Molecular Weight
42kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CENTa1, a noteworthy protein implicated in various cellular processes, has garnered increasing attention in the field of molecular biology and biochemistry. Initially identified in studies exploring protein interactions within the centrosome, CENTa1 plays a crucial role in cellular architecture and mitotic regulation. Over the years, research has revealed its involvement in neural development and function, indicating potential links to neurodevelopmental disorders. The protein's multifaceted roles suggest it may act as a critical mediator between centrosomal function and various signaling pathways. With advances in recombinant DNA technology, scientists have successfully produced CENTa1 as a recombinant protein, allowing for detailed in vitro studies regarding its structural properties and functional significance. The development of purified CENTa1 has enabled researchers to investigate its interactions with other proteins, further elucidating its role in cellular dynamics and disease mechanisms. Understanding CENTa1's molecular functions could provide insights into its involvement in cancer, as aberrations in centrosomal proteins are frequently observed in malignancies. Ongoing studies seek to uncover potential therapeutic targets associated with CENTa1, aiming to translate basic research findings into clinical applications. In essence, the investigation of CENTa1 as a recombinant protein represents a promising frontier in understanding fundamental biological processes and developing novel strategies for treating related diseases.
